Article
A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma
27 Jan 2022
Abstract excerpt
BACKGROUND: Pyroptosis is a new form of programmed cell death (PCD), also known as cellular inflammatory necrosis. Its discovery has resulted in a novel approach to the progression and medication resistance of breast cancer (BC). However, there is still a significant gap in the investigation of pyroptosis-related genes in BC. METHODS: The mRNA expression profiles and clinical data of BC patients were obtained...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
